Top leaders representing America’s advanced medical technology and diagnostics industry came together in Columbus on Monday to discuss pressing public policy issues affecting job creation and medical innovation and to call for the repeal of the more than $20 billion medical device tax set to begin in January 2013.

In Nanofiber Solutions lab (from left), U.S. Reps. Jim Renacci and Pat Tiberi, AdvaMed's Steve Ubl, and Nanofiber Solutions' Jed Johnson and Ross Kayuha

U.S. Reps. Patrick J. Tiberi (R-Ohio) and Jim Renacci (R-Ohio) joined Walt Rosebrough, president and CEO of Mentor, Ohio-based STERIS, and Mike Lynch, executive vice president of Dublin, Ohio-based Cardinal Health, along with AdvaMed President & CEO Stephen Ubl and BioOhio President & CEO Tony Dennis, in the policy discussion. The press came too; see event coverage here (video), there, and here.  

The group had a simple message: The medical technology industry is not only critical to quality health care, but also to the creation of innovative new jobs in Ohio and across the country.  ::read more::

{ Comments on this entry are closed }

Products from five Ohio biomedical companies are getting to tour the country, helping celebrate outstanding U.S. manufacturers that are proud to make their products in the USA.

The “Make It In America” product display features products from 150 U.S. companies, including BioOhio members Cervilenz (made by Interplex), Future Path Medical, CleveMed, Joey Medical (made by DG Medical) and Flocel. The exhibit made its first appearance at last week’s Manufacturing Extension Partnership conference in Orlando, Manufacturing Innovation 2012.

{ Comments on this entry are closed }

Your 2012 BioOhio Scholars!

by Schutte on May 10, 2012

Four Ohio high school seniors have been awarded the 2012 BioOhio Scholarship, designed to encourage and advance bioscience-related STEM education and career interests in Ohio. BioOhio received 345 applications this year, compared to 194 applications in 2011 (a nice little 44% increase for those scoring at home).

This year’s recipients of the non-renewable $1,250 scholarships are:

  • Emily Harker of Mentor High School. Emily will attend Case Western Reserve University with plans to pursue a double major in biomedical engineering and polymer science.
  • Lauren Chen of Bay High School in Bay Village. Lauren will attend The Ohio State University, where she will major in biomedical science.
  • Vivek Chhabria of Olentangy Liberty High School in Powell. Vivek will attend The Ohio State University and pursue a degree in biomedical engineering.
  • Natasha Williamson of Northland High School. Natasha will pursue a biomedical engineering degree at Wright State University. ::read more::

{ Comments on this entry are closed }

Medical technology companies—in Ohio and across the country—are world leaders in the development of new medical devices, diagnostics and essential equipment for patients worldwide, but that leadership is at risk. To outline challenges and opportunities facing the medtech industry, AdvaMed and BioOhio will hold a press conference and advocacy event in Columbus on May 14 at noon.

Featured speakers will include U.S. Rep. Patrick J. Tiberi (12th-OH), U.S. Rep. Jim Renacci (16th-OH), STERIS President and CEO Walter Rosebrough, Cardinal Health Executive Vice President Mike Lynch, BioOhio President & CEO Tony Dennis, and AdvaMed President and CEO Stephen Ubl. Members of the media as well as medtech company representatives are encouraged to attend. ::read more::

{ Comments on this entry are closed }

AssureRx Health launches pharmacogenomic for ADHD

05.08.2012

AssureRx Health has launched a personalized medicine test for the growing number of children and adults diagnosed with attention deficit hyperactivity disorder (ADHD). The new pharmacogenomic test can assist clinicians with important medication decisions that result from genomic differences in how individual patients tolerate ADHD medications. GeneSightRx ADHD analyzes variations in three genes that influence [...]

Read the full article →

Newsticker Rewind, May 7

05.07.2012

Seems like a good timet o pause and reflect on all the good Ohio bioscience news we offer up in the NewsTicker column (over there on the left). In-depth story in today’s Dispatch about the economic impact of health care research in Ohio. Features a quote from BioOhio’s Tony Dennis and uses BioOhio analysis in [...]

Read the full article →

Medical micro-electronics company thinking macro

05.02.2012

BioOhio-member Valtronic, a world leader in designing and manufacturing micro-electronics for medical implants, needs room to grow its U.S. operations. Valtronics USA just acquired a 60,000 square foot facility in Solon, about a mile away from its current location.  Valtronic USA’s new headquarters will house all U.S. operations, including engineering, manufacturing, sales and administrative staff. [...]

Read the full article →

Universities and start-ups share nearly $1 million in Third Frontier awards

04.30.2012

The Ohio Third Frontier Commission recommended $948,109 in funding through the Ohio Third Frontier Technology Validation and Start-up Fund. The Fund promotes the commercialization of Ohio technologies developed by the state’s universities. “Ohio’s institutions of higher education are on the forefront of research that can provide a sizable economic benefit to Ohio companies,” said Christiane [...]

Read the full article →

White House releases Bioeconomy Blueprint

04.27.2012

Yesterday the White House released a national Bioeconomy Blueprint, a comprehensive approach to enhance economic growth and job creation, improve the health of all Americans, and move toward a clean-energy future through scientific discovery and technological innovation. In coordination with the Blueprint’s release, Federal officials also announced a number of new commitments to help the [...]

Read the full article →

EndoSphere scores $1M Innovation Ohio Loan

04.25.2012

EndoSphere has received an Innovation Ohio Loan Fund (IOLF) award of $1 million to support their platform of noninvasive, endoscopically-implantable devices that treat metabolic diseases, including obesity and type 2 diabetes. EndoSphere’s SatiSphere duodenal insert is a non-invasive medical device that improves regulation of appetite and satiety by using the body’s natural physiology. The device [...]

Read the full article →